SCTIMST performs its first LDL apheresis for Familial Hypercholesterolemia, dramatically lowering cholesterol in a 34-year-old patient.
Dublin, April 29, 2024 (GLOBE NEWSWIRE) -- The "Global Apheresis Market Size by Product (Device (Centrifugation, Membrane Separation) Disposable), Procedure (Donor ...
Lipoprotein apheresis involves the extracorporeal removal of LDL and lipoprotein(a) particles from whole blood or plasma by adsorption, precipitation or differential filtration. Used repetitively, ...
Autologous peripheral SCT has largely replaced BMT for the treatment of cancer in both adults and children. Cells are collected by apheresis. The technique has been widely used in France since its ...
Dublin, Feb. 10, 2020 (GLOBE NEWSWIRE) -- The "Apheresis Market by Product [Device (Centrifugation, Membrane Separation) Disposable], Procedure (Donor, Therapeutic ...
In recent years, as many of the diseases for which allogeneic HPC transplantation is indicated are associated with advancing age; this therapy has been increasingly offered to patients in their sixth ...
Global Apheresis Market to Grow at 8% CAGR Driven by Chronic Disease Burden and Blood Demand by 2030
The global apheresis market is expected to grow at a CAGR of ~8% during the forecast period. The market expansion is driven by the increasing prevalence of chronic and autoimmune diseases, growing ...
The global apheresis market is expected to grow at a CAGR of ~8% during the forecast period. The market expansion is driven by the increasing prevalence of chronic and autoimmune diseases, growing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results